Persistence of Human Immunodeficiency Virus and Vaccine Development
Journal of Infectious Diseases & Travel Medicine · 2019
DOI: 10.23880/jidtm-16000126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infectious Diseases & Travel Medicine, 2019. Verfasst von Naoki Yamamoto.
Abstract (Originalsprache)
Highly active anti-retroviral therapy (HAART) capable of suppressing the proliferation of HIV has been developed and this effective therapy for HIV infection has become widely available. Thanks to this, it seems now that the former fatal illness has changed to be immortal. In addition, PrEP (Preexposure prophylaxis) that can effectively prevent HIV infection using anti-HIV drugs has become a hot topic, recently. This pharmacological regimen is used prior to sexual activity in a group at a risk of infection, and the best known is the combination regimen of two reverse transcriptase inhibitors, Truvada [1]. According to a recent study, PrEP is routinely used for two and a half years, effectively preventing HIV infection [2]. Needless to mention, it is not to protect against sexually transmitted diseases and infectious diseases other than HIV. There seems to be a false idea that using a PrEP no longer requires a condom. Of course, although it does not deny the importance of the PrEP and its dissemination, it is apparent that education which does not elicit misunderstanding is also necessary. Otherwise, it could prevent HIV infection but can even help increase other sexually transmitted diseases. In other words, it is recommended that PrEP be used in combination with safer sex practices.
Zitieren
APA
Yamamoto, N. (2019). Persistence of Human Immunodeficiency Virus and Vaccine Development. Journal of Infectious Diseases & Travel Medicine. https://doi.org/10.23880/jidtm-16000126
Vancouver
Yamamoto N. Persistence of Human Immunodeficiency Virus and Vaccine Development. Journal of Infectious Diseases & Travel Medicine. 2019. doi:10.23880/jidtm-16000126
BibTeX
@article{Yamamoto2019,
author = {Yamamoto, Naoki},
title = {Persistence of Human Immunodeficiency Virus and Vaccine Development},
journal = {Journal of Infectious Diseases & Travel Medicine},
year = {2019},
doi = {10.23880/jidtm-16000126}
}
EUVIMED